Published in Breast Cancer Res Treat on January 01, 1997
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer (2009) 1.31
Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). Br J Cancer (1999) 1.26
Pathology characteristics that optimize outcome prediction of a breast screening trial. Br J Cancer (2000) 1.06
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer? Br J Cancer (2003) 0.97
Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. Br J Cancer (2001) 0.86
Retracted Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution. Surg Today (2005) 0.76
A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer. Oncotarget (2016) 0.75
Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example. PLoS One (2016) 0.75
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst (1994) 7.91
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development (1996) 7.00
Assessment and comparison of prognostic classification schemes for survival data. Stat Med (1999) 5.94
A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med (1992) 3.70
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30
Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol (2005) 2.19
Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J (1999) 2.09
Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys (1992) 1.96
Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry (1998) 1.94
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm Genome (2001) 1.89
Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology (1993) 1.85
Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP) Infection (1997) 1.78
Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis (2003) 1.75
A marker for Stevens-Johnson syndrome ...: ethnicity matters. Pharmacogenomics J (2006) 1.73
Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis (2002) 1.72
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70
Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR Am J Neuroradiol (1993) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study. Aliment Pharmacol Ther (2013) 1.57
Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial. Stat Med (1993) 1.55
Statistical analysis of failure times in total joint replacement. J Clin Epidemiol (2001) 1.52
Unsuspected atypical hemispheric dominance for language as determined by fMRI. Epilepsia (2001) 1.52
Neurosteroids: beginning of the story. Int Rev Neurobiol (2001) 1.52
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci (2009) 1.52
Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol (2006) 1.47
Long- and medium-term ozone effects on lung growth including a broad spectrum of exposure. Eur Respir J (2004) 1.47
Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer (2010) 1.46
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group. Int J Cancer (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Melatonin and the ovulatory luteinizing hormone surge. Fertil Steril (1990) 1.41
Scoring system for nosocomial pneumonia in ICUs. Intensive Care Med (1996) 1.41
On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med (2000) 1.40
Prognostic effect of timing of surgery during menstrual cycle in premenopausal breast-cancer patients. German Breast Cancer Study Group. Int J Cancer (1994) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med (1996) 1.39
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group. J Clin Oncol (1994) 1.38
[Severe, reversible cerebral ischaemia following a diving accident]. Dtsch Med Wochenschr (2012) 1.38
Self-expanding and balloon-expandable stents in the treatment of carotid aneurysms: an experimental study in a canine model. AJNR Am J Neuroradiol (1994) 1.36
Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect (1998) 1.35
MRI of spinal cord and brain lesions in subacute combined degeneration. Neuroradiology (1998) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Characterization of al-2, the phytoene synthase gene of Neurospora crassa. Cloning, sequence analysis, and photoregulation. J Biol Chem (1994) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Progesterone synthesis and myelin formation by Schwann cells. Science (1995) 1.32
Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol (2001) 1.32
The validity of inferences based on incomplete observations in disease state models. Biometrics (1991) 1.31
Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res (2000) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology (1989) 1.27
Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J (2002) 1.26
Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). Br J Cancer (1999) 1.26
Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol (1992) 1.24
Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med (2000) 1.24
The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology (1994) 1.24
Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics (2008) 1.22
Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates. Biometrics (2007) 1.22
Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry (1992) 1.20
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. Eur J Cancer (2003) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem (2003) 1.18
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF. Br J Cancer (2002) 1.17
3D blood flow characteristics in the carotid artery bifurcation assessed by flow-sensitive 4D MRI at 3T. Magn Reson Med (2009) 1.16
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood (2000) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Experience with two validation methods in a prevalence survey on nosocomial infections. Infect Control Hosp Epidemiol (1998) 1.12
Sexual differences in the Japanese quail: behavior, morphology, and intracellular metabolism of testosterone. Gen Comp Endocrinol (1983) 1.10
Statistical analysis of quality of life data in cancer clinical trials. Stat Med (1990) 1.09
Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis (2000) 1.08
A nonparametric approach to the statistical analysis of mutagenicity data. Mutat Res (1985) 1.08
[Atlas fractures with paralysis of the caudal cranial nerves. A case report]. Z Orthop Ihre Grenzgeb (1995) 1.08
Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol (1997) 1.08
The sequence complexity of exons trapped from the mouse genome. Curr Biol (1994) 1.08
Parkes Weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography. Eur Radiol (2004) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Osteoporos Int (2003) 1.07
Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci (1985) 1.06
Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye (Lond) (2011) 1.06
Determination of hemisphere dominance for language: comparison of frontal and temporal fMRI activation with intracarotid amytal testing. Neuroradiology (2002) 1.05
Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med (2000) 1.05
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. Br J Cancer (2012) 1.05
Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol (2000) 1.05
Desensitization of tumour Leydig cells by lutropin: evidence for uncoupling of the lutropin receptor from the guanine nucleotide-binding protein. Biochem J (1982) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Rapid isolation of mouse Leydig cells by centrifugation in Percoll density gradients with complete retention of morphological and biochemical integrity. FEBS Lett (1978) 1.04
[Prolongation of hospital stay by nosocomial pneumonia and wound infection]. Dtsch Med Wochenschr (1991) 1.03
Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience (2005) 1.03
Added hospital stay due to wound infections following cardiac surgery. Thorac Cardiovasc Surg (1992) 1.03
Combined stent implantation and embolization with liquid 2-polyhydroxyethyl methacrylate for treatment of experimental canine wide-necked aneurysms. Neuroradiology (2002) 1.03